Matrixyl vs Palmitoyl Pentapeptide-4
A side-by-side research comparison of Matrixyl and Palmitoyl Pentapeptide-4 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Matrixyl | Palmitoyl Pentapeptide-4 |
|---|---|---|
| Full name | Matrixyl (Palmitoyl Pentapeptide-4 / Pal-KTTKS) | Palmitoyl Pentapeptide-4 (Matrixyl Original) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Signals through TGF-B pathway to stimulate fibroblast production of collagen I, III, IV, fibronectin, and hyaluronic acid. Palmitoyl chain enhances penetration. | Mimics collagen breakdown products (matrikines) that signal fibroblasts to produce new collagen matrix components including types I, III, and IV collagen. |
| Molecular weight | 802.1 Da | 802.05 Da |
| Half-life | 6-12 hours (topical depot) | N/A (topical depot effect) |
| Bioavailability | Moderate (topical) | Topical: ~8-12% penetration |
| Typical dose | 2-8% in serum/cream | 2-8% in formulation |
| Frequency | 1-2x daily | 2x daily |
| Route | Topical | Topical serum or cream |
Matrixyl reported benefits
- Stimulates collagen I, III, IV
- Reduces wrinkle depth up to 45%
- Increases skin thickness
- Improves firmness
- Enhances hydration
Palmitoyl Pentapeptide-4 reported benefits
- Proven collagen stimulation
- Wrinkle depth reduction
- Improved skin firmness
- Well-tolerated
Related comparisons
Research and educational reference only. Not medical advice.